Thank you for your response.  To your knowledge has GcMAF been through any clinical trials here or abroad?  If it has and is shown to be effective we can make a lot of noise that Trump will listen to.  The drug companies and FDA have a dual need to keep illnesses front and center.  That gives both of them reasons to require more and more investment which means more profit for drug companies and more staffing and budget money for FDA.  I think Trump is willing to jump in if something is shown to be effective.  We can't let the status quo remain if there is a potential cure sitting in front of us.